Arrowstreet Capital
CNMD icon

Arrowstreet Capital’s CONMED CNMD Stock Holding History

Arrowstreet Capital’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.6M Buy
476,885
+57,793
+14% +$2.08M 0.01% 942
2026
Q1 		$14.8M Buy
419,092
+287,150
+218% +$11.7M 0.01% 840
2025
Q4 		$5.36M Buy
131,942
+111,867
+557% +$4.87M ﹤0.01% 1117
2025
Q3 		$944K Sell
20,075
-4,498
-18% -$233K ﹤0.01% 1612
2025
Q2 		$1.28M Buy
+24,573
New +$1.35M ﹤0.01% 1562
2021
Q1 		– Sell
-2,500
Closed -$280K – 2277
2020
Q4 		$280K Buy
+2,500
New +$237K ﹤0.01% 2134
2020
Q3 		– Sell
-148,329
Closed -$10.7M – 2351
2020
Q2 		$10.7M Buy
148,329
+73,241
+98% +$5.1M 0.02% 755
2020
Q1 		$4.3M Buy
75,088
+47,688
+174% +$4.4M 0.01% 798
2019
Q4 		$3.06M Buy
+27,400
New +$2.92M 0.01% 997
2019
Q2 		– Sell
-197,523
Closed -$16.4M – 1429
2019
Q1 		$16.4M Sell
197,523
-29,479
-13% -$2.14M 0.04% 416
2018
Q4 		$14.6M Sell
227,002
-1,040
-0.5% -$71.2K 0.04% 349
2018
Q3 		$18.1M Buy
228,042
+133,222
+140% +$10.3M 0.04% 310
2018
Q2 		$6.94M Buy
+94,820
New +$6.45M 0.02% 475
2016
Q2 		– Sell
-10,726
Closed -$450K – 1350
2016
Q1 		$450K Sell
10,726
-58,961
-85% -$2.31M ﹤0.01% 1144
2015
Q4 		$3.07M Sell
69,687
-39,821
-36% -$1.73M 0.01% 677
2015
Q3 		$5.23M Hold
109,508
– – 0.02% 518
2015
Q2 		$6.38M Buy
109,508
+16,100
+17% +$868K 0.04% 366
2015
Q1 		$4.72M Sell
93,408
-36,905
-28% -$1.81M 0.03% 421
2014
Q4 		$5.86M Buy
130,313
+23,684
+22% +$993K 0.03% 417
2014
Q3 		$3.93M Buy
106,629
+53,714
+102% +$2.13M 0.02% 445
2014
Q2 		$2.34M Buy
+52,915
New +$2.4M 0.01% 552

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Arrowstreet Capital's CNMD Position: Q2 2026 in Review

Arrowstreet Capital increased its CONMED (CNMD) stake by 14% in Q2 2026, buying an estimated $2.08M and bringing the position to 476,885 shares worth $15.6M. The position accounts for 0.01% of the portfolio, ranked #942.

Arrowstreet Capital first reported a position in CNMD in Q2 2014 and has held it in 21 quarters since. The position peaked at $18.1M in Q3 2018. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Arrowstreet Capital held 476,885 shares of CONMED worth $15.6M as of Q2 2026.
  • Arrowstreet Capital bought 57,793 CONMED shares in Q2 2026, an estimated $2.08M.
  • CONMED made up 0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #942 holding.
  • Arrowstreet Capital first reported a position in CONMED in Q2 2014 and has held it in 21 quarters since.
  • Arrowstreet Capital's CONMED position peaked at $18.1M in Q3 2018.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.